Prognostic and Clinical Value of Interleukin 6 and CD45⁺CD14⁺ Inflammatory Cells with PD-L1⁺/PD-L2⁺ Expression in Patients with Different Manifestation of Ovarian Cancer

Table 2

Levels of IL-6 (pg/ml) in the plasma of patients with ovarian tumors and healthy donors.

Group	Concentration of IL-6 (pg/ml) in the plasma
	Median	Minimum	Maximum
Ovarian cancer ()	21.72	2.98	162.15
Benign tumors ()	13.65	3.90	143.44
Control group ()	6.82	3.90	33.15

in relation to the control group.